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ABSTRACT 
Radiotherapy is used to treat pediatric brain tumors and is often accompanied with 
debilitating late effects, such as cognitive decline. However, the mechanisms are poorly 
understood, and consequently there is still no effective treatment. The inflammatory response 
and microglia activation could change the micro-environment and effect neurogenesis 
resulting in impairment, and this seems to be one important factor eventually leading to 
cognitive decline.  
Lithium has been used clinically many years for bipolar disorder, recent studies revealed 
neuroprotective effects of lithium. In the current thesis we show that lithium normalized 
irradiation induced neural precursor cell death, neurogenesis impairment, inflammation and 
cognitive decline without obvious side effects. Further studies demonstrated transient 
microglial activation and long-term microglia loss after irradiation. To further characterize 
the microglial response after irradiation, our bulk and single cell RNA sequencing data 
revealed that microglial activation returned towards normal levels 1 week after irradiation, 
indicating that microglia activation alone did not sustain the chronic inflammation after 
irradiation in the juvenile hippocampus. So therapeutic interventions aimed at targeting the 
chronic, detrimental inflammation after cranial radiotherapy may be required prior to or 
during radiotherapy in a clinical setting.   
Microglia are involved in almost all CNS diseases either directly or indirectly. Microglial 
depletion and repopulation have shown beneficial effects in many animal disease models; 
however, the signals regulating the microglia repopulation are poorly understood. Here we 
demonstrate that CX3CR1 could regulate residential microglia repopulation and their 
competition with peripheral infiltrating monocytes. Hence, CX3CR1-CX3CL1 axis could be 
manipulated for modulation of repopulation after microglial depletion.  
In summary, our studies firstly demonstrate that lithium is a promising novel treatment for 
radiotherapy-induced intellectual impairment, secondly that there is a narrow time window 
for microglial therapeutic interventions after radiotherapy, and finally that CX3CR1 is crucial 
in the regulation of microglial repopulation after depletion.  The knowledge generated in this 
thesis provides the foundation for further research, including clinical trial.  
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1 Introduction 
1.1   Radiotherapy 
Brain tumors are the most common pediatric solid tumors and represent 30% of all 
childhood solid tumors. On average, the annual incidence is 4.6 per 100,000 children, and 
81% of them survive more than 5 years (Childhood Cancer Incidence and Survival in 
Sweden 1984-2010, Childhood Cancer Epidemiology Group).  
Brain radiotherapies include whole-brain radiotherapy and local radiotherapy [1]. Different 
conformal strategies have been developed and used in clinical practice in order to reduce 
damage to the surrounding tissues; however, cognitive decline still occurs [2]. Moreover,  
whole-brain and spinal cord irradiation is still commonly used in all cases of 
medulloblastoma (MB) and in the prevention of cranial metastases [3, 4], and it is also used 
for the treatment of selected cases of  leukemia and lymphoma, while whole body 
irradiation (IR) can be used prior to hematopoietic stem cell transplantation [5]. Generally 
speaking, radiotherapy combined with surgery and/or chemotherapy can be viewed as 
standard therapy for malignant (high grade) brain tumors [6].  
It is important to note that children may experience relatively more profound impairments 
after radiotherapy than adults [7, 8]. Radiotherapy can induce cognitive decline later in life, 
such as memory, attention and executive function deficits [7, 9-11]. The increased number 
of survivors due to the improvement of treatments has revealed the side effects of IR, 
drawing more and more concerns about the quality of life for survivors. Neuro-
psychological outcomes depend on different factors including radiation dose (number of 
fractions and dose per fraction), gender, irradiation volume (whole brain irradiation or focal 
irradiation), age at the time of treatment, and the period of time after treatment [7, 8, 12]. 
Irradiation can cause damage in different regions of the brain including the cortex, white 
matter and hippocampus. Specifically, damage to the hippocampus after IR is responsible 
for learning and memory disabilities, while frontal cortex injury after IR is responsible for 
executive disability [1, 13]. Loss of white matter induced by IR is also associated with 
cognitive decline [14, 15]. These potential side effects as well as central nervous system 
(CNS) damage, are probably due to inhibition of neurogenesis, neuro-inflammatory 
responses, apoptosis and oxidative stress induced by IR [16-20]. Moreover, IR-induced 
neurogenic micro-environment alternations, such as microglial activation or inflammatory 
responses, is a critical factor changing the cell fate of neural precursors and eventually 
decreasing neurogenesis [21].  
1.2    IR-induced neuroinflammation in the juvenile brain 
Neuroinflammation is one of the most important mechanisms contributing to or even 
causing brain injuries in CNS disorders such as multiple sclerosis [22], brain trauma [23], 
hypoxia-ischemia [24], neurodegeneration disorders [25] and irradiation brain injury [26]. 
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Inflammation can usually be divided in two phases: acute and chronic inflammation. Some 
have proposed that chronic brain injuries can be treated by blocking the transition from 
acute to chronic inflammation [25]. Chronic inflammation might also influence the brain 
long after IR, causing micro vessel damage in the hippocampus [27]. 
Microglia are local macrophages in the CNS, and they are the first line of defense after 
brain injury [28]. Under physiological conditions microglia are vital for brain development 
and work by phagocyting dead cells or pruning spines. However, microglia activation is 
always followed by a release of cytokines and chemokines, which changes the CNS 
microenvironment affecting neurogenesis and neuron maturation [21, 29]. Furthermore, 
active astrocytes can release cytokines and chemokines and contribute to the inflammatory 
response [30]. 
1.2.1    Inflammatory response in the juvenile hippocampus after IR 
Neurons and glia can be regenerated throughout life in two neurogenic areas, the subgranular 
zone (SGZ) of hippocampus and the subventricular zone (SVZ) of the lateral ventricles [31, 
32]. Although these processes are conserved throughout life, they are more profound in 
children. The neurogenesis in the hippocampus is critical for memory formation and 
cognitive functions. The inflammatory response after IR in the hippocampus is summarized 
in Table 1. 
Microglia activation and cell loss after IR 
We have previously shown that  the number of both total and active microglia in the SGZ 
were significantly higher 6 and 24 h after a 6 Gy single dose of IR in postnatal day 11 rats 
[33]. Consistent results were shown in another study where mice were subjected to IR at 
postnatal day 10 [34]. IR reduced microglial numbers as early as one week after IR in the 
SGZ, while total numbers of microglia did not change significantly in the granule cell layer 
(GCL) of rats subjected to IR at postnatal day 9 [35]. Other studies also found that IR 
increased microglial numbers in the SGZ during the acute phase, but decreased the number of 
microglia during the chronic phase, presumably due to microglial death [36, 37]. 
Astrocytosis after IR 
Only two studies have been published referring to the astrocyte response after IR in the young 
brain hippocampus. In the molecular layer of the hippocampus, astrocyte density (as judged 
by GFAP positive cell numbers) increased by12% after IR, even at a long-term time point 
[38]. Another study found astrocyte hypertrophy rather than hyperplasia 7 days after IR in 
postnatal day 9 rats [39].  
Cytokine and chemokine release after IR 
Our study demonstrated that the cytokine interleukin 1 alpha (IL-1α), and the chemokines 
CCL2 and GRO/KO significantly increased in the SGZ of the hippocampus 6 h after IR in 
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postnatal day 11 rats, but returned to normal levels 24 h after irradiation [33]. Long lasting 
chronic inflammation (IL-6 and CCL2) was detected in both juvenile mice (postnatal day 10) 
and adult mice after IR [37]. In support of this, another mouse study showed that both CCL2 
and IL-1β were increased 6h after IR, while IL-6 decreased 1 week after IR in postnatal day 9 
mice [36]. In a study using microsphere-based xMAPTM technology to quantify cytokine 
protein expression in the neurogenic regions, CCL2 and IL-α levels were significantly 
increased 6h after IR on postnatal day 9 rats. They found that the increased CCL2 was mainly 
produced in astrocytes using immunohistochemistry [39].  
Hip Age Dose 
(Gy) 
6h after IR 24h after IR 1w after IR 4w after IR 1 year 
after IR 
 
Mice P10 6 MG number  
(SGZ) 
Active MG  
(SGZ) 
 
    Wang, et al., 
2017 
Mice P10 8 MG number  
(GCL & SGZ) 
 
MG number  
(GCL & SGZ) 
 
MG number  
(GCL & SGZ) 
 
MG number  
(GCL & SGZ) 
 
 Han, et al., 
2017 
Mice P10 8 
 
Active MG  
(SGZ) 
Active MG  
(SGZ) 
 
Active MG  
(SGZ) 
 
  Han, et al., 
2017 
Mice P10 8 MG number 
(DG) 
IL-6, CCL-2  
(Hip) 
 
MG number 
(DG) 
IL-6, CCL-2  
(Hip) 
 
MG number 
(DG) 
IL-6, CCL-2  
(Hip) 
 
MG number 
(DG) 
IL-6, CCL-2  
(Hip) 
 
  
Han, et al., 
2017 
Mice P14 8  
 
 
 
   Astrocyte 
Number 
(ML) 
Kalm, et al., 
2013 
Rats P11 6 MG number  
(SGZ) 
Active MG  
(SGZ) 
IL-1α, CCL-2, 
GRO/KC,  
IL-1β (hip） 
MG number  
(SGZ) 
Active MG  
(SGZ) 
IL-1α, CCL-2, 
GRO/KC 
(hip)  
 
    
 
Zhou, et al., 
2017 
Rats  P9 8 MG number  
(DG) 
 
    Sabel, et al., 
2017 
Rats P9 6 CCL-2,  
 IL-1β (hip） 
 
 
 
 
 
 
IL-6 (Hip) MG number  
(GCL & ML) 
Active MG  
(GCL & ML) 
 Blomstrand, et 
al., 2014 
Rats  
 
P9 8 
 
MG number  
(Hip) 
Active MG  
(Hip) 
 
 MG number  
(Hip) 
 
  Kalm, et al., 
2009 
Rats 
 
P21 8 
 
  MG number  
(Hip) 
 
  Kalm, et al., 
2009 
Rats P9 8 CCL-2,  
 IL-1α (hip） 
 
 Astrocyte 
hypertrophy 
  Kalm, et al., 
2009 
         
Table 1. Inflammatory responses in the hippocampus. 
p = postnatal, Dose = IR dose, Gy = Gray, h = hours, SGZ = sub granular zone, GCL= granular cell layer, DG 
= dentate gyrus, hip=hippocampus, ML= molecular layer. Red means the values increased. Black means no 
change, blue means the values decreased. Decreases or increases only refer to the protein level.  
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1.2.2    Inflammatory response in the juvenile subventricular zone (SVZ) after IR 
The SVZ is one of the two regions where neurogenesis was found to take place throughout 
the life span. The new born neurons in the SVZ migrate to the olfactory bulb and mature into 
local interneurons [40]. As in the SGZ of the hippocampus, the SVZ is highly vulnerable to 
IR due to the continuously dividing cells. 
Changes in microglial number after IR 
Seven days after 8 Gy IR on postnatal day 9 rats, the microglial density significantly 
decreased in SVZ [35]. Another study using both postnatal day 9 and day 21 rats subjected to 
8 Gy IR found that microglial numbers increased in both groups 6h after IR; however, 7 days 
after IR microglial number decreased only in postnatal day 9 rats [41]. 
Cytokine and Chemokine release after IR 
CCL2 expression increased significantly in the SVZ 6 h after IR in postnatal day 9 rats, due 
to activation of astrocytes and microglia [39]. No data are available for other cytokines and 
chemokines in the SVZ after IR.  
1.2.3    Inflammatory response in the corpus callosum after IR 
The development of white matter consists three phases: myelination of axons during the first 
3 months following birth, followed by the thickening of the myelin sheaths and the 
maturation at 48 months. During the first phase of development, the white matter is highly 
vulnerable to injury after IR [7]. 
Microglial response after IR 
Eight Gy IR results in decreased microglial numbers in the corpus callosum in postnatal day 
9 rats, but not in 21-day-old rats [41]. Another study showed that male but not female mice 
showed increased microglial numbers in the corpus callosum 4 months after IR in postnatal 
day 14 mice [42].  
1.2.4    Inflammatory response in the cerebellum after IR 
The cerebellum was thought to be responsible for motor function only; however, an 
increasing number of new studies are hinting at important roles for the cerebellum in 
cognitive development and cognitive functions [43-49]. The data are summarized in Table 2. 
Microglial response after IR 
Many proliferating cells still existed in EGL of the cerebellum when mice were subjected to 
IR [50], Therefore, Similar results that the number of microglia increased both 6 and 24 h 
after IR, were found in EGL of cerebellum as in the SGZ and SVZ [34, 51];  
Cytokine and chemokine release after IR 
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Our previous research showed that the blood brain barrier in this region is more vulnerable to 
IR compare to other brain regions, and that the relative lack of growth (“loss of volume”) 
after IR was bigger in the cerebellum than the other regions, revealing that the postnatal 
growth continues long after birth in this region [26]. Therefore, the inflammatory response 
after IR in the cerebellum may be stronger than in other brain regions. Pro-inflammatory 
cytokines like IL-1α, IL-1β and CCL2 were increased at both 6 and 24 h after IR, while the 
anti-inflammatory cytokines IL-6 , IL-18, CX3CL1 or GRO/KC, GM-CSF and VEGF only 
increased 24 h after IR [51]. As mentioned before, the EGL still had many proliferating cells 
when the mice were subjected to IR, which explains the extensive amount of cell death that 
accompanied the severe inflammation.  
Cereb      
 Age 
 
Dose (Gy) 6h after IR 24h after IR  
Mice 
 
P10 6 
 
 
MG number (EGL) 
 
MG number (EGL) 
 
Wang, et al., 
2017 
Rats P11 6 MG number (EGL) 
IL-1α, IL-1β, CCL-2 
IL-18, IL-6, GRO/KC 
GM-CSF, VEGF 
(Cereb) 
  
Zhou, et al., 
2017 
Table 2. Inflammatory responses in cerebellum 
Cereb = Cerebellum, P = postnatal, Gy=Gray, EGL = external granule cell layer   
Red means that the values increased. Black means no change.  
 
1.2.5    Inflammatory responses in other brain areas after IR 
Increased IL-1β expression was detected in the hypothalamus after IR in postnatal day 18 
rats, influencing hypothalamic-pituitary-adrenal axis regulation [52], and perhaps explaining  
the changes in pituitary hormone levels  found in another study [33]. In the cortex, CCL2, 
GRO/KC, IL-1α, IL-18, TNF-α, IL-2 and IL-12p70 expression was up-regulated  6 h after IR 
in postnatal day 9 rats [39].  
1.3    Neuroinflammation as a potential target for the side-effects caused by RT 
Blocking inflammation using indomethacin, a commonly used anti-inflammatory drug, could 
rescue neurogenesis in adult rats after IR [53].  Peroxisomal proliferator-activated receptors 
(PPARs) also showed an anti-inflammatory response after IR [19]. Only the absence of 
CCL2 was enough to normalize the neurogenesis loss in an adult mouse study [54]. Recently, 
lithium has also been indicated as a promising and safe pharmacotherapy to protect the brain 
by reducing cell death and neuroinflammation in the hippocampus of juvenile mice [55]. Our 
previous data showed that lithium can prevent IR-induced neuroinflammation, including pro-
inflammatory cytokines, even with the activation of microglia [33]. Along this line, 
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autophagy could be another mechanism that contributes to side effects after IR. A mouse 
study revealed that Atg7 KO mice had decreased levels of IL-1β, IL-4, IL-6 and CCL2 after 
IR [34]. Another study tested hypothermia in irradiated rats, but the protective effect was not 
significant [35]. Inhibiting microglia by using a colony-stimulating factor 1 (CSF1R) receptor 
blocker such as PLX5622 was found to reduce inflammation (as judged by monocyte 
accumulation) and normalize the cognitive dysfunction after three fractions of 3.3 Gy whole-
brain irradiation in adult mice [56], although this study neglected the effects of microglial 
depletion on normal brain development and behavior itself [57]. Also, peroxisome 
proliferator/activated receptors were tested in the IR mouse model as an anti-inflammatory 
strategy, and the cognitive outcomes were improved and inflammation responses were 
reduced [58]. 
 
1.4    Microglial depletion and repopulation 
1.4.1    Microglial depletion 
Microglial depletion methods 
Different ways of depleting microglia have been developed recently and are mainly classified 
into three categories: genetic, conditional genetic and  pharmacological depletion [59]. In 
genetic depletion in mice, the microglia usually have a mutation in the genes that are critical 
for microglia survival and the mice carrying these mutations usually die before adulthood 
[60, 61]; thus, genetic depletion is not widely used for microglial depletion and repopulation.   
The conditional genetic microglial depletion models include the use of CD11b-HSVTK, 
CX3CR1creER:iDTR and CX3CR1creERRosa26DTA mouse strain. In a CD11b-HSVTK mouse 
strain with ganciclovir (GCV) injection, GCV can be monophosphorylated by HSVTK, and 
further transforms into a triphosphate form with cellular toxicity. All CD11b+ cells are 
supposed to be eliminated, leading to high mortality [62]. To avoid targeting cells outside the 
CNS, the GCV was injected intra-cerebroventricularly (i.c.v.), and the efficacy of microglial 
depletion could reach 95% after 4 weeks of treatment, but with mortality and BBB damage 
causing the infiltration of  peripheral cells [63]. Later, the CX3CR1creER:iDTR strain was 
developed. Due to the rapid turnover of peripheral monocytes, microglia can be specifically 
depleted by injecting Diphtheria toxin (DT) several weeks after tamoxifen (Tam) injections, 
and the microglial depletion rate can reach > 80%, without peripheral infiltrating monocytes 
contributing to the repopulation [64, 65]. The CX3CR1creERRosa26DTA mice strain was 
generated by crossing CX3CR1creER and Rosa26DTA mouse strains, DT can be produced 
intracellularly. Specifically, Cre recombinase was released after tamoxifen injections and cut 
the floxed-STOP cassette of DT. DT starts to express and eventually leads to cell death. The 
efficacy of microglia depletion can reach > 90% but with peripheral infiltrating  monocytes 
contribute to the repopulation in this approach [66].  
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Clo-Lip can be phagocytosed by microglia, accumulated free form of clodronate eventually 
leads to microglia apoptosis [67, 68]. Clo-Lip is either injected intracerebroventricular to 
deplete microglia in the whole brain [69] or injected intracerebral to deplete microglia in 
specific brain regions[70, 71]; however, Clo-Lip has been shown damage other brain cells 
and blood vessels [68]. CSF1R is crucial for microglial survival and development [72]. 
CSF1R KO mice lack microglia and die before adulthood [73, 74]. Different CSF1R 
inhibitors including PLX3397, PLX647, Ki20227 and GW2580 have been tested, and 
PLX3397 eventually shows the most robust microglia depletion [75]. Newly repopulated 
microglia without contribution from the periphery was noted after microglial depletion by 
PLX3397 and PLX5622 and PLX3397 can be given orally in chow, which means it can be 
applied to any strains and species. but PLX3397 is not specific to CSF1R, it also can inhibit 
other kinases including FLT3, PDGFR and KIT [76, 77]. Later,  PLX5622 was developed 
with a more selective profile for CSF1R over FLT3 and KIT [78]. 
Microglial depletion in the healthy brain 
Microglia depletion may affect other cell types in the brain. Western blot data showed no 
changes in levels of microtubule-associated protein 2 (MAP2), hexaribonucleotide binding 
protein-3 (NeuN), or oligodendrocyte transcription factor (Olig2) after microglial depletion; 
however, astrocyte markers such as GFAP and S100 were significantly increased, while the 
BBB and cognitive behavior were not affected by either short or long term microglial 
depletion in adult mice [75]. Another adult of adult mice showed transiently spatial memory 
impairment after microglial depletion [71]. However, early life microglial depletion at 
postnatal day 1 and 4 induced social, mood-related and locomotor behavior impairments [69]. 
Microglial depletion in different diseases 
Microglial depletion as a novel tool to study the role of microglia has widely broadened our 
knowledge of microglia under both physiological and pathological conditions. Microglia play 
important roles in different CNS diseases, and targeting or depleting microglia has become a 
promising way to treat different CNS diseases that involve dysfunctional microglia [79]. 
Microglial depletion shows beneficial outcomes in different disease models including 
experimental autoimmune encephalomyelitis (EAE), intracerebral hemorrhage, Alzheimer’s 
disease (AD), neuropathic pain, IR-induced memory deficits, detrimental pathological 
outcomes in amyotrophic lateral sclerosis (ALS), cerebral ischemia, Parkinson’s disease (PD) 
and coronavirus encephalitis [79]. This means that microglia play distinct roles in different 
diseases and that different therapies targeting microglia should be applied accordingly. 
Moreover, microglial depletion at different time points could also yield different results. For 
example, microglial depletion in 5-month-old mice in an AD model showed no alternation in 
Aβ formation or maintenance [63]; however, early application of  long-term microglial 
depletion significantly reduced neurotic plaque deposition, accumulation of intraneuronal 
amyloid and pre-fibrillar oligomers [80].     
Microglial depletion in the human brain  
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Early studies from Plexxikon showed that microglial depletion could reduce glioblastoma 
(GB) burden and spread. PLX3397 significantly reduced GB cell invasion when co-cultured 
with microglia, and PLX3397 could reach GB and surrounding tissues without causing BBB 
damage. A clinical phase II study of 37 recurrent GB patients showed that PLX3397 also 
reduced microglial numbers in human brains, but without improvement of clinical outcomes. 
Therefore, combined therapies need to be further studied [81]. 
1.4.2    Microglial niche repopulation 
Resident microglia contribute to the repopulation of the microglia niche 
Both genetic and pharmacological microglial depletion allow microglia to rapidly repopulate 
the brain, indicating the inherent property of microglial repopulation independent of the way 
in which they are depleted [72]. Interestingly, one study showed that microglial niche 
repopulation is proportional to the microglial depletion rate, in other words the more 
microglia that are depleted, the faster the new microglia will repopulate, Further, several 
cycles of microglial depletion will delay the microglia repopulation [82].  
The CX3CR1CreER:iDTR microglial depletion model showed that in the absence of IR, 
microglia repopulated exclusively from the internal microglial pool [65]. Elmore and his 
colleagues demonstrated that the repopulation of microglia after depletion by CSF1R 
inhibitor PLX3397 did not stem from the peripheral macrophages. They further found that 
repopulated microglia were mainly from nestin+ microglia precursor cells rather than the 
surviving microglia [75]. However, this was overturned by a more recent microglia depletion 
study that used PLX5622, in which the authors demonstrated using parabiosis that 
repopulated microglia were only from the remaining resident microglia. In fact, newly 
repopulated microglia were from less than 1% of the surviving microglia. Moreover, the 
newly formed microglia transiently expressed nestin, and none of the repopulated microglia 
originated from nestin+ non-microglial cells. Another study revealed that repopulated 
microglia after depletion by PLX5622 are not derived from neuroprogenitor cells (nestin+) or 
the oligodendrocyte precursor cells (NG2+ or PDGFra+), but were instead from self-renewal 
of the CX3CR1 lineage without the contribution of peripheral macrophages [72].  
One study showed that microglia repopulated from clonal clusters with minimal migratory 
diffusion by using Microfetti labeled Brainbow mice, and impaired microglia repopulation 
was found in NF-kb KO mice [72]. In a Cx3cr1CreER study, after microglial depletion the 
remaining microglia that escaped depletion started to proliferate in clusters and then move 
away to fill the empty microglial niche. Furthermore, the proliferating microglia expressed 
high levels of IL1R, and IL-1R antagonist impaired the process of microglia repopulation 
[65]. 
Single cells analysis of both repopulated and resident microglia showed that newly 
repopulated microglia expressed higher levels of cell cycle genes (Cdk1 and Mki67), cell 
survival genes (Bcl2a1a and Bcl2a1d) and microglial migration related genes (Cd36), which 
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indicated high proliferation and migration of repopulating microglia. The authors further 
compared the brains before and after microglia depletion and repopulation, the whole brain 
transcriptome was not influenced, and only three differentially expressed genes, including 
Gabra6, Cbln3, Fat2, were observed. Furthermore, the gene profile showed no difference 
after challenging the resident microglia and repopulated microglia with LPS, indicating the 
similarity of function between newly repopulated microglia and resident microglia [83]. 
During microglial repopulation the regenerating microglia recapture immature signatures 
during early repopulation and re-express mature makers during later phase of repopulation. 
The authors also found that the highly proliferating repopulated microglia also experience 
active cell death [72]. Another study showed that 2 weeks after microglial repopulation by 
PLX3397, the repopulated microglia are morphologically indistinguishable from the original 
resident microglia [75]. 
 Peripheral monocytes repopulate to the microglial niche and become microglia-like cells 
After IR and microglial depletion using a CX3CR1CreER mice model, BM-derived cells 
infiltrated the CNS and became microglia-like cells, resembling resident microglia in terms of 
distribution and morphology 12 weeks after microglial depletion. However, the microglia-
like cells are transcriptionally distinct from resident microglia, expressing lower levels of 
Hexb, P2yr12, Olfml3, Mertk, Pros1, Entpd1, C1qa and Tmem119 [65]. Unlike in other 
microglial depletion models, peripheral-derived monocytes populated the CNS microglial 
niche after depletion by administration of tamoxifen in the Cx3cr1CreER/+R26DTA/+ mice, and 
the resulting microglia adopted similar phenotypes but remained transcriptionally, 
epigenetically and functionally distinct. This process is independent of BBB leakage and is 
regulated by type 1 interferon [66].   
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2   The aims of the thesis 
The overall aim of this thesis is to investigate potential strategies to ameliorate the often 
debilitating late-appearing side effects after RT to the juvenile brain. Specifically, to 
investigate the effects of pharmacological lithium treatment, and to explore microglia 
dynamics after IR or after depletion and during repopulation.  
Specific aims: 
1. To evaluate the therapeutic and toxic effects of lithium as a potential pharmacological 
treatment for the side effects after RT in juvenile mice 
 
2. To characterize the short and long term microglial response after IR in juvenile mice 
 
3. To characterize the microglial transcriptome by bulk and single-cell RNA sequencing at 
different time points after IR in juvenile mice 
 
4. To investigate the contribution the Cx3cl1-Cx3cr1 axis on microglial repopulation after 
depletion 
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3   Methods 
3.1 Animal models 
The CNS develops continually during childhood and adolescence; however, there are no 
systematic studies comparing the IR-induced brain injury between human and rodents at 
different ages. In papers 1 and 2 we subjected postnatal day 11 rats and postnatal day 10 mice 
to IR. The CNS developmental level at  postnatal 10 or postnatal 11 in a rodent is 
approximately equivalent to 2-years-old human or younger [84]. However, radiotherapy is 
typically avoided in patients younger than 4 years of age, which approximately is equal to 
postnatal day 21 in rodents [84]. Thus, to be more clinically relevant, we used postnatal day 
21 mice in paper 3. 
Sex is another factor that may contribute to the susceptibility to side effects after IR. It has 
been shown that girls are more like to develop IR-induced cognitive decline than boys[85]. 
Males were used in paper 1; both sexes were used in paper 2, but without comparison 
between the two; Females were used in paper 3. Gender differences should be taken into 
consideration in future IR-induced brain injury studies.  
6 Gy and 8 Gy are approximately equivalent to 12 Gy and 16 Gy, respectively, using repeated 
2 Gy fractions, according to the linear-quadratic model [86] and an α/β ratio of 3 for late 
effects in normal brain tissue, representing a moderate radiation dose in clinical settings. 
From a practical point of view, single dose of 6-8 Gy is often used in rodent models.  
Paper 1 described the use of Wistar rat pups (Charles River, Germany) to study lithium and 
IR. Postnatal day 11 rats were anesthetized by an i.p. injection of 50 mg/kg tribromoethanol. 
The rats were placed in a prone position and the whole brain was irradiated with single dose 
of 6 Gy. Sham animals were anesthetized but not irradiated.  
Paper 2 described the use of C57BL/6 mice (Charles River, Germany), 
Cx3cr1GFP/+CCR2RFP/+ mice generated by crossbreeding Cx3cr11GFP/GFP and CCR2RFP/RFP 
(Jackson Laboratory, US), and Casp8fl/fl LysMCre+/- or Casp8fl/fl LysMCre-/- mice generated 
by crossbreeding Caspase-8 fl/fl and Casp8fl/fl LysMCre+/-. The mice were anesthetized with 
isoflurane and irradiated in a cabinet X-ray irradiator to a dose of 8Gy at postnatal day 10 or 
90.  
Paper 3 described the use of C57BL/6 mice (Charles River, Germany), with the same IR 
procedure as paper 2 
Paper 4 described the use of Cx3cr1CreER/+Rosa26DTA/+ mice generated by crossbreeding 
Cx3cr1CreER/CreER (Jackson Laboratory, US) with Rosa26 DTA/DTA (Jackson Laboratory, US) 
mice and Cx3cr1GFP/+ mice generated by crossbreeding Cx3cr11GFP/GFP (Jackson Laboratory, 
US) and C57BL/6 mice (Charles River, Germany). 
3.2 Behavioral evaluation 
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Paper 1 described the use of behavioral tests, including openfield and object recognition. The 
mice were allowed to move on a 100 x100 cm open-field arena, with a camera automatically 
recording the movements of the mice. The speed and distance reflected the mouse activity, 
while staying in the central zone (30x30cm) reflecting less anxiety. Object recognition was 
tested the next day, consisting of two trials, where two identical objects were put in the arena. 
The mice were allowed to freely explore them to get familiar with the objects for 5 minutes. 
Six hours later, one of the objects was replaced by a new, differently shaped object, and the 
total time spent exploring the new object and the old object were recorded. The health mice 
usually spend more time exploring the new object since the mice have an innate preference 
for novelty.  
3.3 Bulk and single cell RNA sequencing  
Paper 3 described the use of bulk and single cell RNA sequencing. For the bulk RNA 
sequencing, the RNA was isolated using a miRNeasy micro kit (Qiagen, 217084). The library 
was prepared using a QIAseq FX single cell RNA library kit (Qiagen), and then sequence on 
an Illumina HiSeq 2000. Single-cell sequencing was performed using the 10x Genomics 
Chromium method and sequenced using an Illumina HiSeq 2500. 
Paper 4 described the use of bulk and single cell RNA sequencing. For bulk RNA seq, the 
cells were sorted into Smart-Seq lysis buffer directly. The library was built by following the 
Smart-Seq protocols, and then sequenced on an Illumina HiSeq 2000. In the single RNA seq, 
we re-analyzed the same data that was generated in paper 3.  
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4   Results and discussion 
4.1 Paper 1: Lithium as a promising drug for radiotherapy induced pediatric brain 
injury 
Radiotherapy is an indispensable brain tumor treatment; however, it also causes severe late 
effects, such as cognitive decline including deficits in memory, executive functions and 
attention, especially in children [7]. However, as of yet there is no effective treatment for 
radiotherapy-induced side effects in children. The only strategy that has been clinically tested 
in children is exercise, which partially restore neurogenesis and behavioral deficits in mice 
[87] and has positive effects also in human [88, 89]. Lithium has robust neuroprotective roles 
after radiotherapy [18]; however to be able to move to clinical trials we have to test the long-
term effects of lithium on juvenile animals. 
We first found that relatively high concentrations of lithium are toxic to tumor cells, but not 
to the immortalized neural progenitor cells. Then, when we irradiated an IR resistant 
medulloblastoma cell line, and found that 10 mM of lithium increased the IR sensitivity, 
without any signs of protective effects on the tumor cells with either 1 or 10mM of lithium. 
This is consistent with other studies indicating that lithium do not protect tumor cells [90], 
and acts as a radiosensitizer [91]. 
As described above, the neurogenic regions, including the SGZ, are particularly susceptible to 
IR, and the loss of neural precursor cells in the SGZ is associated with cognitive decline. We 
next found that lithium is able to inhibit and delay cell death in the SGZ and increases 
neurogenesis following IR. We further assessed a behavior test, novel object recognition; and 
as we hoped, lithium prevented the IR-induced cognitive deficits. We further found that 
lithium could prevent IR-induced acute inflammation in the hippocampus, but had no effect 
on numbers of microglia of SGZ. Moreover, IR can also induce systemic effects through 
radiation-induced endocrinopathy [5]. Body weight gain was delayed 4 weeks after IR, but 
lithium failed to rescue the body weight gain loss. It is well-known that patients treated with 
craniospinal radiotherapy often need replacement therapy with thyroid hormone and growth 
hormone. One study showed that IR induces deficits of pituitary weight and related 
hormones, and the deficits are bigger in younger adult rats [92].  Here, we found in the 
juvenile rat brain, that IR reduced or even abolished pituitary-related hormonal increases 
when body weight and the concurrent metabolic needs increased, Lithium restored TSH and 
GH levels after IR and reduced the IR-induced BDNF increase.  
Finally, we checked the possible side effects that may arise from administration of lithium. 
Blood samples were collected at different time points after IR and lithium injections. 
Creatinine levels in the blood can be used to monitor kidney function, and increased levels 
may indicate kidney damage. Creatinine increased along with the rapid growth, as expected 
when the muscle mass increases, but this was not different between lithium- and vehicle-
treated mice. In summary, lithium has multiple effects on IR-induced juvenile rat brain 
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injury, and without any obvious side effects, making it a promising pharmacological 
treatment for radiotherapy-induced late-appearing side effects.   
4.2 Paper 2: Transient microglia accumulation with long lasting loss of microglia after 
IR 
In paper 1, we discussed that lithium can reduce inflammatory response, but not microglial 
activation. However, microglial response time after IR is poorly understood. IR can induce 
cognitive decline in both juveniles and adults; however, the mechanisms seem to be different. 
Here, postnatal day 10 and day 90 mice were irradiated, after which microglial accumulation 
was more pronounced in juvenile mice than adult mice. Both juvenile and adult mice 
demonstrated a transient microglial increase, followed by a decrease in microglial numbers 
over time due to microglia cell death. The increased microglial number in the juvenile brain 
was at least partly due to proliferation after IR, but no Ki67+ microglia were detected at any 
time after IR in adult mice. The increased microglial numbers of the SGZ may also be a result 
of migration from the neighboring areas. One transcriptional study of microglia indicated an 
aging-like microglial profile after IR. The study further demonstrated an inverse correlations 
between CSF1R and IR [93]. Given that CSF1R is important for microglial survival and 
development, IR-induced CSF1R impairment may be the reason behind the induction of 
microglial cell death.   
Whether peripheral monocytes contribute to the microglial pool after IR is not clear. Here, we 
used a Cx3cr1GFP/+CCR2RFP/+ strain, for which in the CNS, GFP was exclusively expressed in 
microglia and RFP was expressed on peripheral “inflammatory” monocytes, identified as 
Ly6chiCCR2+Cx3cr1-, which are commonly found in inflamed tissues. No RFP+ microglia 
were detected in either juvenile or adult brains, indicating that no peripheral infiltrating 
monocytes contributed to the microglial pool after IR. Monocytes may however have down-
regulated CCR2 after infiltrating into the brain [94], so we used an RFP antibody to amplify 
the signal; still, no RFP+ cells were detected, and no BBB leakage was detected, as judged by 
the lack of extravascular albumin. These data are consistent with a previous study, which 
only found infiltrating monocytes in the brain after high-dose IR [95]. Long-lasting 
expression of CCL2 was detected in both juvenile and adult hippocampus, and CCL2 is 
known to regulate the BBB and attract infiltrating peripheral monocytes [96]. Together with 
our data, increased CCL2 alone is not enough for BBB opening and peripheral monocyte 
infiltration. 
Microglial activation and inflammation were also compared between juvenile and adult mice 
after IR. Both morphological changes and CD68 expression indicated a more pronounced and 
long-lasting microglial activation in the juvenile brain (until after one week in the juvenile 
brain, as compared to 24 hours in the adult brain). Long-lasting IL-1β expression was also 
detected in both juvenile and adult brains, indicating chronic inflammation. IL-1 β increases 
BBB opening by targeting astrocytes [97]. It also impairs SGZ neurogenesis [98], which 
maybe another mechanism leading to IR-induced cognitive decline.   
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4.3 Paper 3: Dynamic microglia alterations in juvenile brain 
In paper 2, we discussed that the increase in microglial numbers during the acute phase in the 
SGZ was at least partly due to the microglial proliferation in the juvenile brain and may also 
involve microglial migration from neighboring regions of the dentate gyrus. The SGZ 
microglia were transiently active until one week after IR in the juvenile brain, and there was 
no peripheral monocyte contribution to the microglial pool, neither in juvenile, nor in adult 
brains. Microglia display distinct molecular changes across brain developmental stages, 
which may influence microglial responses in different pathological CNS conditions [99]. 
Here we used bulk and single-cell RNA sequencing to unveil dynamic microglial molecular 
profiles in irradiated juvenile brains.  
Consistent with paper 2, histology showed that juvenile microglia react most exuberantly 
early after IR and return toward baseline after one week. Overall, microglial density 
decreased in the entire DG, indicating microglial loss after IR. Double staining of microglial 
markers Iba-1 and active caspase-3 in the acute phase and microglial pouches containing 
caspase-3+ cellular structures were observed, indicating that microglial numbers increased 
transiently as well as that their activation was associated with engulfment of apoptotic cells in 
the SGZ. Furthermore, bulk RNA sequencing of the microglia of the hippocampus showed 
that a majority of upregulated genes were related to lysosomal biogenesis, modulation of 
cytoskeleton and cell adhesion, which are important for microglial phagocytic activity [100-
102]. The vast neural precursor cell death-induced microglial activation and phagocytic 
activity in the juvenile brain may be the reason for the distinct microglial and inflammatory 
response in the juvenile brain, different from the adult brain after IR, since in the later there 
are much fewer dying precursors.   
After IR, only the microglia in the SGZ of the hippocampus were active due to the vast 
amount of cell death. The microglia returned to baseline, morphologically, when the dead 
cells were cleared. These finding strongly indicate that IR-induced cell death is a key trigger 
for microglial activation [103]. Since the bulk RNA sequencing includes all the microglia in 
the hippocampus, and thus cannot distinguish the SGZ microglia from the microglia of other 
parts of the hippocampus, we next performed single-cell RNA sequencing.  
Cx3cr1+ microglia were fluorescence-activated cell sorting (FACS) sorted from the 
hippocampus 6 hours and 1 week after IR for single-cell RNA sequencing. As expected, the 
one-week IR microglia clustered together with the sham microglia, and only the 6 hours IR 
microglia clustered separately, which was consistent with our bulk RNA sequencing and 
histology study. Further clustering analysis revealed that different clusters adopted different 
profiles after IR, indicating considerable heterogeneity of the microglia in the hippocampus. 
Moreover, we detected genes associated with both pro- and anti-inflammatory states 
expressed together in individual microglia. This was consistent with our bulk RNA 
sequencing data showing transcriptional changes overlapping between pro- and anti-
inflammatory genotypes 2, 6 and 24 hours after IR. But bulk sequencing doesn’t allow us to 
determine if the pro- and anti-inflammatory genes were expressed in different cells or the 
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same cell. This overturns the M1 and M2 classification of microglia [104], which were only 
validated in vitro, since the in vivo model failed to reveal a distinct M1 or M2 phenotype 
[105-107]. Velocity analysis showed that one cluster displayed greater transcriptional activity 
compared to other clusters and expressed high CCL4 and CCL3. Immunohistochemical 
analysis identified that this cluster of microglia as the phagocytically active SGZ microglia, 
which stained positive for CCL4.  
To further compare the juvenile and adult microglia after IR，and the aging microglia, gene 
set enrichment analysis (GSEA) was used to compare data from our juvenile microglia after 
IR with data available from with previously published work on adult microglia after IR or 
ageing. The results showed that except for the one-week timepoint after IR, which appeared 
to return to normal, the GSEA further confirmed our histology and bulk RNA sequencing 
data showing the transient nature of microglial alteration after IR in the juvenile brain. 
However, the adult microglia after IR showed a high degree of overlap of hallmark gene sets 
with ageing microglia one month after IR, indicating that they hold an aged microglial 
phonotype following IR, consistent with previously reported results [93]. 
4.4 Paper 4: Cx3cr1 regulated microglia repopulation after depletion 
Microglia are derived from immature macrophages at E8.0, which develop into A1 (CD45+ c-
kitloCx3cr1-) and further mature into A2 (CD4+ c-kit-Cx3cr1+) cell types. The expression of 
Cx3cr1 in microglia is initiated from the A2 phase at E9.0 and is maintained in microglia in 
the later phase. Therefore, Cx3cr1-GFP and Cx3cr1Cre/ERT2 mice can be used from E9.0 onward 
to label and target microglia [74, 108]. Cx3cr1 is exclusively expressed by microglia in the 
CNS, and the Cx3cl1/ Cx3cr1 axis plays a key role in microglia-neuron contact [109, 110]. 
Moreover Cx3cr1 is widely used to genetically label microglia by inserting EGFP [75, 111], 
and thus can be easily used for microglial tracing, visualization and sorting [74, 112-115]. 
Furthermore Cx3cr1cre and Cx3cr1Cre/ERT2 are commonly used for studying microglial fate 
mapping [116, 117] and depletion [57, 118, 119] by modifying the genome of the microglia 
with floxed specific target genes [120]. Previously publications reviewed the current available 
approaches to specifically deplete microglia by targeting Cx3cr1 [121, 122], and these methods 
have important implications for understanding microglia and associated CNS diseases. In the 
current study, we found that approximately 1% of all microglia escaped genetic labelling, and 
that these microglia were transcriptionally and functionally different from the modified ones. 
In microglial depletion based on the expression of Diphtheria toxin in cells carrying the Cre-
ERT2, after injection of tamoxifen, the unmodified microglia were not affected, as expected. 
During repopulation, these unmodified microglia appeared to have an advantage when 
competing with surviving resident and modified microglia and with infiltrating macrophages. 
The unmodified cells established their territories in large colonies originating from the small 
numbers of surviving cells without mixing with the other two cell types, while the latter two 
established smaller interspersed colonies, mixing with each other.  
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Further analysis revealed that the wild type microglia that had escaped genetic modification 
expressed higher levels of Cx3cr1 compared to the Cx3cr1Cre/ERT2/YFP microglia, 
approximately twice as high, possibly because in the modified cells one allele is replaced 
with the inserted Cre/ERT2/YFP. We hypothesized that Cx3cr1 may be a critical regulator 
for microglial repopulation in the CNS and that higher levels of Cx3cr1 entail a competitive 
advantage in this context, and that Cx3cl1- Cx3cr1 signaling is related to the repopulation 
advantage observed. This notion is supported by the finding that microglial repopulation after 
depletion using CSF1 blockade was slower in the retina in Cx3cr1 deficiency and accelerated 
with exogenous Cx3cl1 administration [123].  Therefore, we depleted microglia in Cx3cr1-
deficient mice, and 6 weeks later, the Cx3cr1-deficient brains were fully repopulated. 
However, the majority of the repopulated microglia were derived from infiltrating 
macrophages. Meanwhile, in the Cx3cr1Cre/ERT2/+ brains, around 50% of the repopulated cells 
were derived from resident microglia and 50% were derived from infiltrating macrophages, 
indicating that Cx3cr1 is essential for resident microglia repopulation but not for peripheral 
macrophage infiltration.  
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4   Future Perspectives  
4.1 IR-induced cognitive decline 
Predicting which patients will suffer from cranial RT induced intellectual impairment 
Random coefficient models were development to predict intellectual outcome decline in MB 
patients after cranial RT [124]; however, different individuals responded differently, and it is 
still difficult to predict who will develop cognitive impairment and who will not [125]. It is 
conceivable that biomarkers of neuroinflammation reflective of brain injury, could help predict 
RT-induced intellectual outcome. We propose that at least some of the markers we identify in 
the brain tissue also can be detected in the blood, and could serve as such biomarkers. 
The mechanisms of IR-induced cognitive decline need to be further investigated 
IR can induce neurogenesis impairment, white matter injury, neuroinflammation and vessel 
damage; however, the exact mechanisms leading to cognitive decline are still unclear, and there 
are no effective therapeutic interventions [126, 127]. New technologies, such as in vivo 
imaging, single cell RNA sequencing and mass cytometry should be applied in future research 
to uncover the mystery of IR-induced brain injury.  
4.2 Combined radiotherapy and immunotherapy  
Immunotherapy has been successfully used in the treatment of tumors like malignant 
melanoma and lung cancers [128-136]. However, it is less successful with CNS tumors, since 
there are no or very few infiltrating immune cells in these tumors, except in the case of  high 
grade GB and brain metastases [137-139]. The complicated immune suppression in the tumor 
microenvironment of GB makes it hard to treat using one immunotherapy intervention alone 
[138], and combined immunotherapies may increase the risk of side effects. Radiotherapy 
could increase T cell infiltration to the tumor tissues, and immunotherapies could further boost 
the immune response [140-142]. Therefore, RT and immunotherapy seem to be a good 
combination for brain tumors; however, the interplay between RT and immunotherapy needs 
to be further investigated, especially in children. The immune system is not fully mature until 
12 years of age, so the immune response maybe different from adults, and pediatric tumors 
usually have a low mutational burden compared with tumors in adults. Thus, the check point 
blockade strategies maybe less effective [143]. Further, most preclinical modeling of immune 
therapeutics has been done with adult mice, thereby hampering the development of pediatric 
immunotherapy [144, 145]. Therefore, pediatric brain tumor immunotherapies urgently require 
more research.  
4.3 Microglial depletion and repopulation 
 Microglial depletion has shown beneficial effects in different diseases [79]; however, many 
questions need to be solved before it can be applied in the clinic. PLX3397 has been used in a 
clinical trial for GB, depleting microglia in order to reduce the tumor burden and 
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invasiveness, but it showed no beneficial effects [79]. Studies combining PLX3397 together 
with RT are still ongoing (https://clinicaltrials.gov/ct2/show/NCT01790503). As CSF1R 
blockade drugs including PLX3397 and PLX5622, not only target microglia, but also all 
other cells expressing CSF1R, including peripheral monocytes and macrophages, a microglia-
specific depletion drug needs to be developed.  
Repopulated microglia all come from the surviving microglia after depletion. Both the 
repopulated microglia and the brain with the newly repopulated microglia will resume the 
same transcriptomic profile as it had before the depletion [83]. Microglia replacement therapy 
in disease models has been limited by the transcriptomic similarity before and after depletion; 
however, microglia replacement by peripheral monocytes or even engineered cells, is still 
promising. The mechanisms regulating the repopulation of both resident microglia and 
peripherally derived cells need to be further investigated. Our current paper 4 indicates that 
CX3CR1 regulates resident microglia and peripheral monocyte repopulation.   
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